Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Capital Expenditures Growth (3y) (2012 - 2026)

Resmed (RMD) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -14.20%
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -9.20%
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 73.21%
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 14.07%
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -16.94%
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 5.34%
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 5.49%
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -10.72%
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -15.23%

Historic Data

Download Data
DateValue
Jun 30, 2026 14.07%
Mar 31, 2026 5.31%
Dec 31, 2025 1.43%
Sep 30, 2025 13.93%
Jun 30, 2025 2.21%
Mar 31, 2025 -24.56%
Dec 31, 2024 -12.11%
Sep 30, 2024 -13.26%
Jun 30, 2024 -3.75%
Mar 31, 2024 -7.02%
Dec 31, 2023 -12.57%
Sep 30, 2023 30.54%
Jun 30, 2023 24.23%
Mar 31, 2023 -0.88%
Dec 31, 2022 2.90%
Sep 30, 2022 8.62%
Jun 30, 2022 8.86%
Mar 31, 2022 47.55%
Dec 31, 2021 18.16%
Sep 30, 2021 28.14%